PD-1 blockade exacerbates Mycobacterium tuberculosis infection in rhesus macaques

The potentiation of T cell–mediated antitumor responses achieved in multiple types of cancer via inhibition of the PD-1 checkpoint pathway has led to suggestions that anti–PD-1 therapy might also boost T cell immunity in chronic infections including tuberculosis. Kauffman et al . examined the effect of anti–PD-1 antibody treatment on the clinical course of Mycobacterium tuberculosis (Mtb)…

Read the full article here

Related Articles